TXMD Stock Summary and Trading Ideas (Therapeuticsmd | NASDAQ:TXMD)

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Therapeuticsmd trades on the NASDAQ stock market under the symbol TXMD.

As of January 9, 2026, TXMD stock price climbed to $2.16 with 126,083 million shares trading.

TXMD has a beta of 1.43, meaning it tends to be more sensitive to market movements. TXMD has a correlation of 0.09 to the broad based SPY ETF.

TXMD has a market cap of $25.00 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, TXMD traded as high as $5.64 and as low as $.70.

The top ETF exchange traded funds that TXMD belongs to (by Net Assets): VTI, VXF.

TXMD has outperformed the market in the last year with a price return of +94.6% while the SPY ETF gained +19.0%. TXMD has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +103.8% and +24.1%, respectively, while the SPY returned +3.7% and +0.5%, respectively.

TXMD support price is $1.92 and resistance is $2.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TXMD shares will trade within this expected range on the day.